Revlixen 10 Capsules — Lenalidomide 10 mg (21 Caps) Everest

Indicated for the treatment of adult patients with:

• 🔹 Multiple Myeloma (MM): As combination therapy or maintenance treatment following autologous stem cell transplantation.
• 🔹 Myelodysplastic Syndromes (MDS): Specifically for transfusion-dependent anemia associated with a deletion 5q cytogenetic abnormality.
• 🔹 Mantle Cell Lymphoma (MCL): For patients who have relapsed or progressed after other treatments.

Sales Unit: Box of 21 capsules (3 strips of 7), 10 mg strength.

⚠️ APPLICATION INSTRUCTIONS:

• Administration: Swallow capsules whole with water at the same time each day. Do not break, chew, or open.
• Standard Cycle: Typically taken on days 1-21 of repeated 28-day cycles.
• Dose Modification: This 10 mg strength allows for precise dose reduction in patients experiencing adverse events or with renal impairment.
• ✋ Safety Warning: Pregnant women must not handle the blister or capsule due to risk of absorption through the skin.

• ⛔ Pregnancy & Breastfeeding: STRICTLY CONTRAINDICATED. Known to cause severe birth defects.
• Women of childbearing potential (unless adhering to a strict pregnancy prevention program).
• Children under 18 years of age.
• Hypersensitivity to Lenalidomide.
• Severe renal failure (requires careful monitoring).

Strict medical supervision is required. Common side effects include:

• 📉 Blood Disorders: Neutropenia (low white blood cells), thrombocytopenia, and anemia. Weekly blood tests are often required initially.
• 🩸 Clotting Risk: Increased risk of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).
• 🤢 Systemic: Fatigue, gastrointestinal issues (diarrhea/constipation), rash, and muscle spasms.